Pharma and Life Sciences Consulting The complexity of risks facing life sciences and pharmaceutical companies is greater than ever before. From IP protection to areas such as drug pricing, reduced funding for all but specific biotechnology research, tax reform, supply chain challenges and tariffs, we understand the impact these risks have on how life sciences and pharmaceutical companies do business. Protiviti provides life sciences consulting services in Hong Kong for pharmaceutical, biotechnology and medical device organisations. We build custom solutions that maximise your chances for success, deploying a tailored, multidisciplinary team of professionals who fit your situation and company culture.We collaborate with drug manufacturers, life sciences companies, medical device manufacturers, biotech companies and CRO's to confidently embrace the future.Our pharma consulting services in Hong Kong support organisations from R&D through to commercialisation, improving operational efficiency, strengthening regulatory compliance, and enabling growth in a highly regulated environment.In Hong Kong, life sciences organisations operate within a complex regulatory environment shaped by the Department of Health and increasing cross-border integration with mainland China. Companies must balance innovation with compliance, supply chain resilience and evolving patient expectations. What we do Our services Leadership Our consulting services for pharma and life sciences industry in Hong Kong Our experts deliver life sciences consulting services in Hong Kong tailored pharmaceutical, biotech and medical device companies across the following areas: Pro Briefcase Technology strategy and operations and software services Companies often make limited investments within IT, as investments are primarily focused on R&D activities and funding clinical trials. We help emerging companies develop and implement roadmaps for success by supporting digital transformation in life sciences, including IT strategy, system modernisation, and scalable platforms for clinical and commercial operations. Pro Building office Supply chain and operations solutions We help life sciences organisations in Hong Kong build resilient supply chain operations, addressing global disruptions, cross-border trade challenges and increasing demand for critical products. Pro Document Consent Cybersecurity and privacy services As more systems move to virtual environments, the risk of cyber threats and liabilities grows. We help build a comprehensive cybersecurity strategy to protect intellectual property, clinical trial data, employee data and patient information from theft or misuse. Pro Document Folder Public company transformation services Making the leap from an R&D-focused organisation to a commercial organisation requires the right combination of resources, processes and technology. We support organisations transitioning from R&D to commercialisation, helping scale operations, strengthen governance and meet compliance requirements, including IPO readiness and public company expectations. Why do pharma and life sciences companies in Hong Kong choose consulting services? Pharma and life sciences companies in Hong Kong face increasing pressure from regulatory complexity, digital transformation, cybersecurity risks and supply chain disruption. Organisations must manage compliance while accelerating innovation, improving patient outcomes and scaling operations in a competitive market.At Protiviti Hong Kong, our life sciences consulting services help organisations strengthen governance, manage risk, improve operational efficiency and accelerate transformation across the value chain. We work with pharmaceutical manufacturers, biotech firms, medical device companies and healthcare innovators to address business-critical challenges. Featured insights and client stories SURVEY 2026 Global Transformation Survey 8 min read 2026 Global Transformation Survey findings reveal how C-suite alignment, shared performance metrics and technology modernisation help organisations achieve transformation success. CLIENT STORY Global Life Sciences Giant’s Digital SAP Transformation Provides Operational Improvements 5 min read Over the course of a multi-year digital transformation, this global healthcare leader embarked on an ambitious migration of its complex global businesses to SAP S/4HANA and a suite of supporting enterprise finance, data, and integration capabilities.... CLIENT STORY Healthcare Innovator Builds a Reputation for Sustainability 5 min read Explore how this U.S. healthcare innovator drives sustainability in healthcare through comprehensive GHG management and strategic ESG initiatives. FLASH REPORT Trump 2.0: The First 100 Days – A Look at Industry Winners and Losers 24 min read When Donald Trump took office on January 20 as the 47th President of the United States, U.S. chief executive officers (CEOs) were looking forward to 2025 with renewed optimism based on the expectation that business conditions would improve.  ... WHITEPAPER Top Compliance Priorities for U.S. Healthcare Organisations in 2025 2 min read Protiviti’s risk and compliance experts weigh in on the top compliance priorities for healthcare organisations in 2025 and what these changes mean under a new administration.Providers, payers, and life sciences organisations must refine their... CLIENT STORY A Healthcare Giant's Journey to Evaluate Risk, Strengthen Data Use Licensing Agreements with Third-Party Vendors 5 min read Organisations should regularly monitor obligations and compliance within their third-party contract universe. CLIENT STORY Leading Biotechnology Company Enhances AWS Environment Security and Risk Control 3 min read A leading biotechnology company that develops life-transforming medicines has worked for decades to improve the lives of those who rely on their work. But recently, they found themselves in need of assistance to enhance the security of their AWS... Previous Article Pagination Button Button Button Button Next Article Leadership Adam Johnston Adam is the country market lead for Hong Kong. With over 15 years’ experience, he has spent much of his career consulting to Fortune 500 organisations, helping them solve complex transformation, and resourcing programs and projects. Adam’s specialisation is ... Learn More Jenny Wong Jenny is a managing director with over 12 years’ experience specialising in financial services, finance transformation, and change management. She is a key member of the global enterprise solutions team working on client engagements for Protiviti and Robert Half.  ... Learn More